Spring direct naar de hoofdnavigatie of de inhoud
‘To explore, together with a client, how the best IP protection can be obtained is for me the logical next step after an invention has been made.’
Frits Michiels

Frits Michiels

  • Life Sciences
  • European and Dutch Patent Attorney
  • Senior Associate

Frits Michiels has had an extensive scientific career in both knowledge institutes and biotech companies. From 2004, he was employed as IP manager at Galapagos Genomics BV and subsequently also at other Dutch biotech startups, such as Agendia and Merus. He has worked for V.O. since 2006.

Continue reading

He is specialized in biochemistry, molecular biology, cell biology, diagnostics, signal transduction, and medical biotechnology. His clients are primarily knowledge institutes and start ups. He is involved in patent prosecution and strategic advice.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Merus (2006)
  • Galapagos Genomics (1999-2005)
  • Senior Scientist at the Netherlands Cancer Institute (1994-1998)
  • Post-Doc, Amsterdam Medical Center (1991-1993)
  • PhD research at Max Planck Institute for Biochemistry, Munich (1985-1990)

Education

  • PhD in Genetics, Radboud University Nijmegen (1990)
  • MSc in Microbiology, Radboud University Nijmegen (1984)

Publications

  • Michiels, GAM Damages extended to after termination of a tort. MIP Vol 205: 94-95 (2011)
  • JP ten Klooster, EE Evers, L Janssen, LM Machesky, F Michiels, P Hordijk and JG Collard. Biochem J. 397, 39–45 (2006)
  • GJ Arts, E Langemeijer, R Tissingh, L Ma, H Pavliska, K Dokic, R Dooijes, E Mesić, R Clasen, F Michiels, J van der Schueren, M Lambrecht, S Herman, R Brys, K Thys, M Hoffmann, P Tomme, H van Es. Genome Res 13, 2325-32 (2003)
  • A Malliri, RA van der Kammen, K Clark, M van der Valk, F Michiels & JG Collard. Nature 417, 867-871 (2002)
  • F Michiels et al. Nature Biotech 20, 1154-1157 (2002)
  • R Engers, E Springer, F Michiels, JG Collard, HE Gabbert. J Biol Chem 276, 41889-97 (2001)
  • WO2002057463 Swap/counter selection; a rapid cloning
  • WO2002070744 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds method
  • WO2005124342 Methods and means for treatment of osteoarthritis

Languages

  • English
  • Dutch
  • German

Also see these experts

Mark Einerhand

Mark Einerhand

  • European and Dutch Patent Attorney
  • Partner
Frits Schut

Frits Schut

  • European and Dutch Patent Attorney
  • Partner
More experts

News

Well-prepared for the future

Column by Cees Jansen, former chairman V.O. After 26 years, I have left V.O. I was chairman for the last 12 years, a task that I have passed on to Herman Witmans. This is a good moment to look back.Continue reading

Recommended by JUVE Patent

In May 2020, V.O. was recommended by JUVE Patent in the categories Patent Filing and Prosecution. Listed as recommended individuals are Marco Box, Leo Jessen, Bernard Ledeboer, Otto Oudshoorn and Jetze Beeksma.Continue reading

Two prizes for V.O.

This January, the Netherlands’ office of V.O. was crowned the best patent firm of 2019. This selection as the ‘Netherlands Patent Attorney Firm of the Year’ was announced by the Intellectual Asset Management (IAM) and World Trademark Review (WTR).Continue reading

Events

Webinar: getting started with patents

On 27 August 2020, we will organise the first webinar in a series of six about dealing strategically with your intellectual property. In the webinar 'Getting Started with Patents', patent attorney Henri van Kalkeren will take you through the most important topics about patents, so you can be more profitable with your innovation. Continue reading

Knowledge for Growth 2020

Don’t miss the 2020 digital edition on 9 and 10 September and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be participating in the 16th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. Continue reading

Sustainable Plastics & Materials Expo 2020

ATLAS Theater, Raadhuisplein 100, Emmen, Netherlands

The first edition of the Sustainable Plastics & Materials Expo 2020 will take place in Chemical Cluster Emmen in the Netherlands. Continue reading